Literature DB >> 24912786

Urinary bladder cancer risk variants: recent findings and new challenges of GWAS and confirmatory studies.

Silvia Selinski1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24912786     DOI： 10.1007/s00204-014-1297-4

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN： 0340-5761            Impact factor:   5.153


× No keyword cloud information.
  7 in total

1.  Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2017-12-08       Impact factor: 4.068

2.  Additional evidence for the 'wimp SNP' concept of carcinogenesis.

Authors:  Hermann M Bolt
Journal:  EXCLI J       Date:  2017-11-20       Impact factor: 4.068

3.  The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness.

Authors:  Stanley Teleka; Sylvia H J Jochems; Karin Jirström; Tanja Stocks
Journal:  Cancer Med       Date:  2022-03-13       Impact factor: 4.711

4.  Impact of urinary bladder cancer risk variants on prognosis and survival.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2014-11-28       Impact factor: 4.068

5.  The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2014-11-03       Impact factor: 4.068

Review 6.  rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: A systematic review and meta-analysis.

Authors:  Chong Ma; Liyan Gu; Mingyuan Yang; Zhensheng Zhang; Shuxiong Zeng; Ruixiang Song; Chuanliang Xu; Yinghao Sun
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.

Authors:  Silvia Selinski; Meinolf Blaszkewicz; Katja Ickstadt; Holger Gerullis; Thomas Otto; Emanuel Roth; Frank Volkert; Daniel Ovsiannikov; Oliver Moormann; Gergely Banfi; Peter Nyirady; Sita H Vermeulen; Montserrat Garcia-Closas; Jonine D Figueroa; Alison Johnson; Margaret R Karagas; Manolis Kogevinas; Nuria Malats; Molly Schwenn; Debra T Silverman; Stella Koutros; Nathaniel Rothman; Lambertus A Kiemeney; Jan G Hengstler; Klaus Golka
Journal:  Carcinogenesis       Date:  2017-12-07       Impact factor: 4.944
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.